Literature DB >> 11948756

Mechanisms of deep brain stimulation.

Jonathan O Dostrovsky1, Andres M Lozano.   

Abstract

High frequency electrical stimulation by means of electrodes implanted into the brain (deep brain stimulation; DBS) recently has become an accepted technique for the treatment of several movement disorders and in particular for Parkinson's disease. Because the effects produced by DBS are similar to those produced by making a lesion in the same region, it has been proposed that the overall effect of DBS is to inhibit the neural activity in the region stimulated. However, whether this is actually the case is presently not known, but various mechanisms have been proposed in an attempt to explain how DBS could mimic the effects of a lesion. We describe the various mechanisms that have been proposed to account for the inhibition or disruption of the pathologic outflow by high-frequency DBS, ranging from depolarisation block to stimulation-evoked release of gamma-aminobutyric acid and describes preliminary findings that show that stimulation within these structures can result in inhibition. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11948756     DOI: 10.1002/mds.10143

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  76 in total

1.  Bilateral high-frequency electrical impulses to the thalamus reduce voice tremor: acoustic and electroglottographic analysis. A case report.

Authors:  Jean Richard Moringlane; Manfred Pützer; William J Barry
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-24       Impact factor: 2.503

Review 2.  Stereotactic implantation of deep brain stimulation electrodes: a review of technical systems, methods and emerging tools.

Authors:  Simone Hemm; Karin Wårdell
Journal:  Med Biol Eng Comput       Date:  2010-06-02       Impact factor: 2.602

Review 3.  Mechanisms of deep brain stimulation.

Authors:  Todd M Herrington; Jennifer J Cheng; Emad N Eskandar
Journal:  J Neurophysiol       Date:  2015-10-28       Impact factor: 2.714

Review 4.  Neuromodulation interventions for addictive disorders: challenges, promise, and roadmap for future research.

Authors:  Primavera A Spagnolo; David Goldman
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

5.  Subthalamic nucleus stimulation in Parkinson's disease : anatomical and electrophysiological localization of active contacts.

Authors:  F Godinho; S Thobois; M Magnin; M Guenot; G Polo; I Benatru; J Xie; A Salvetti; L Garcia-Larrea; E Broussolle; P Mertens
Journal:  J Neurol       Date:  2006-06-20       Impact factor: 4.849

6.  Axonal and somatic filtering of antidromically evoked cortical excitation by simulated deep brain stimulation in rat brain.

Authors:  T Chomiak; B Hu
Journal:  J Physiol       Date:  2006-12-14       Impact factor: 5.182

Review 7.  Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

Authors:  Thomas Wichmann; Mahlon R DeLong
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

8.  GABA(A) autoreceptors enhance GABA release from human neocortex: towards a mechanism for high-frequency stimulation (HFS) in brain?

Authors:  Michela Mantovani; Andreas Moser; Carola A Haas; Josef Zentner; Thomas J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-03-19       Impact factor: 3.000

9.  Mechanisms of unilateral STN-DBS in patients with Parkinson's disease : a PET study.

Authors:  Noritoshi Arai; Fusako Yokochi; Takashi Ohnishi; Toshimitsu Momose; Ryoichi Okiyama; Makoto Taniguchi; Hiroshi Takahashi; Hiroshi Matsuda; Yoshikazu Ugawa
Journal:  J Neurol       Date:  2008-06-20       Impact factor: 4.849

10.  High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.

Authors:  Emilie Lacombe; Carole Carcenac; Sabrina Boulet; Claude Feuerstein; Anne Bertrand; Annie Poupard; Marc Savasta
Journal:  Eur J Neurosci       Date:  2007-09-06       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.